Nisco James 4
4 · LISATA THERAPEUTICS, INC. · Filed Jan 13, 2025
Insider Transaction Report
Form 4
Nisco James
SVP, Fin/Treas, Chief Actg Off
Transactions
- Tax Payment
Common Stock
2025-01-09$3.80/sh−781$2,968→ 23,907 total - Award
Stock Option (Right to Buy)
2025-01-09+7,000→ 7,000 totalExercise: $3.80From: 2025-01-09Exp: 2035-01-09→ Common Stock (7,000 underlying) - Tax Payment
Common Stock
2025-01-09$3.80/sh−1,137$4,321→ 24,688 total - Award
Common Stock
2025-01-09+15,000→ 27,956 total - Tax Payment
Common Stock
2025-01-09$3.80/sh−2,131$8,098→ 25,825 total - Tax Payment
Common Stock
2025-01-10$3.73/sh−416$1,552→ 23,491 total
Footnotes (5)
- [F1]Represents 15,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.
- [F2]Includes 17,357 unvested restricted stock.
- [F3]Shares withheld as payment of a tax liability on vesting of restricted stock.
- [F4]Includes 16,624 unvested restricted stock.
- [F5]One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third anniversaries of the grant date.